News
Displaying 1–10 of 580
-
Nanoscope’s investigational RP treatment MOGENRY advances toward FDA approval
Research NewsOne-time injection could treat RP patients regardless of underlying genetic mutation
-
Stargardt Disease Research Advances
Research NewsRecent developments in research on Stargardt disease.
-
Leber Congenital Amaurosis Research Advances
Research NewsRecent developments in research on Leber congenital amaurosis.
-
Age-Related Macular Degeneration Research Advances
Research NewsRecent developments in research on age-related macular degeneration.
-
Retinitis Pigmentosa Research Advances
Research NewsRecent developments in research for retinitis pigmentosa treatments.
-
Foundation News
The new name honors the decades of leadership and giving by Foundation co-founder Gordon Gund and his family, honoring the Fund’s evolution into one of the most innovative venture philanthropy models in the retinal disease market.
-
First patient treated with potential retinitis pigmentosa treatment from Sumitomo Pharma America
Research NewsCell therapy DSP-3077 is in Phase 1/2a clinical trials
-
Tarsus plans to purchase Alkeus, developer of emerging Stargardt treatment
Research NewsDeal marks another step as gildeuretinol advances towards patients
-
PRIMA retinal implant restores sight in patients with geographic atrophy from AMD
Research NewsProduct launched in Europe, U.S. approval in progress
